Literature DB >> 7682404

Characterization of an antigenic site on glycoprotein 13 (gC) of equid herpesvirus type-1.

R Sinclair1, B J Moult, J A Mumford.   

Abstract

Six monoclonal antibodies directed against EHV-1 glycoprotein 13 were characterized. Five antibodies neutralized EHV-1 and were directed against a single antigenic site which comprised type-specific and type cross-reactive epitopes. Inhibition of monoclonal antibody binding to this site by post-infection equine sera suggests that it is a target of host antibody during natural infection with either EHV-1 or EHV-4.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7682404     DOI： 10.1007/bf01316908

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  25 in total

1.  Location of open reading frames coding for equine herpesvirus type-1 glycoproteins with homology to gE and gI of herpes simplex virus.

Authors:  D M Elton; W A Bonass; R A Killington; D M Meredith; I W Halliburton
Journal:  Am J Vet Res       Date:  1991-08       Impact factor: 1.156

2.  Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.

Authors:  G Kümel; H C Kaerner; M Levine; C H Schröder; J C Glorioso
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

3.  Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.

Authors:  S D Marlin; T C Holland; M Levine; J C Glorioso
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

Review 4.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.

Authors:  G P Allen; J T Bryans
Journal:  Prog Vet Microbiol Immunol       Date:  1986

5.  [Characterization of an equine abortion virus from Poland and comparison with known equine rhinopneumonitis virus strains].

Authors:  A Mayr; H O Böhm; J Brill; S Woyciechowska
Journal:  Arch Gesamte Virusforsch       Date:  1965

6.  Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.

Authors:  P X Guo; S Goebel; M E Perkus; J Taylor; E Norton; G Allen; B Languet; P Desmettre; E Paoletti
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

7.  Detection of influenza nucleoprotein antigen in nasal secretions from horses infected with A/equine influenza (H3N8) viruses.

Authors:  R F Cook; R Sinclair; J A Mumford
Journal:  J Virol Methods       Date:  1988-05       Impact factor: 2.014

8.  Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model.

Authors:  A Stokes; A H Corteyn; L A Pullen; T R Doel; D M Meredith; R A Killington; I W Halliburton; G R Whittaker; L A Wheldon; L Nicolson
Journal:  J Gen Virol       Date:  1991-04       Impact factor: 3.891

9.  Identification and nucleotide sequence of a gene in equine herpesvirus 1 analogous to the herpes simplex virus gene encoding the major envelope glycoprotein gB.

Authors:  J M Whalley; G R Robertson; N A Scott; G C Hudson; C W Bell; L M Woodworth
Journal:  J Gen Virol       Date:  1989-02       Impact factor: 3.891

10.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.